MorphogeniQ
ActiveSummary
MorphogeniQ has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4,056 and a net result of €3,056. Its solvency ranks better than 28% of 13,749 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 1.3% (low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 23-07-2024 Normal situation
- Activity
- Agents specialised in the wholesale of other particular products NACE 46180and 2 others
- Establishment unit
- 2.363.524.071 2370 Arendonk, since 23-07-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 07-08-2024
Board and ownership
- Luc MeeuwissenDirector
- Meeuwissen,Luc François Isabelleall the sharesdeed of 28-11-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.3%
- Gross margin
- €6,470
- Turnover
- ≈ €55,000
- estimated
- Profit
- €3,056
- Equity
- €4,056
- Total assets
- €33,113
- 2025 accounts filed 25 days after the deadline
Score breakdownraises riskFounded in 2024Size: total assets €33,113Equity €4,056 (12.3% of total assets)lowers riskLiquidity: current ratio 1.14, cash €9,106Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 25% of them on solvency, 33% on liquidity and 45% on profitability.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Searched, nothing found (1)
Financials
Financials · financial year 2025, micro format
2025 annual accounts filed 25 days after the deadline Filed on 25 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00421947.
Annual accounts 2025 filed on 25-08-2026 at the NBB
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Investments
| Item | 2025 |
|---|---|
| Financial fixed assets | €0 |
Source: notes to the 2025 annual accounts (statement of fixed assets)
| Line | 2025 |
|---|---|
| Other operating charges640/8 | €957 |
| Gross operating margin9900 | €6,470 |
| Operating profit (loss)9901 | €5,513 |
| Financial income75/76B | €0 |
| Recurring financial income75 | €0 |
| Financial charges65/66B | €1,690 |
| Recurring financial charges65 | €1,690 |
| Profit (loss) for the period before taxes9903 | €3,823 |
| Income taxes67/77 | €767 |
| Profit (loss) for the period9904 | €3,056 |
| Profit (loss) for the period to be appropriated9905 | €3,056 |
| Line | 2025 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €33,113 | |
| Current assets29/58 | €33,113 | |
| Stocks and contracts in progress3 | €14,759 | |
| Stocks30/36 | €14,759 | |
| Amounts receivable within one year40/41 | €9,248 | |
| Trade receivables40 | €4,559 | |
| Other amounts receivable41 | €4,689 | |
| Cash at bank and in hand54/58 | €9,106 | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €33,113 | |
| Equity10/15 | €4,056 | |
| Contributions10/11 | €1,000 | |
| Reserves13 | €3,056 | |
| Distributable reserves133 | €3,056 | |
| Amounts payable17/49 | €29,056 | |
| Amounts payable within one year42/48 | €29,056 | |
| Trade debts44 | €27,732 | |
| Suppliers440/4 | €27,732 | |
| Taxes, remuneration and social security45 | €767 | |
| Taxes450/3 | €767 | |
| Other amounts payable47/48 | €558 | |
| Line | 2025 |
|---|---|
| Profit (loss) for the period9904 | €3,056 |
| Operating cash flow (approximation) | €3,056 |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 7,976 companies had the same profile as MorphogeniQ has now. Two years later, 94.4% were still going and 3.6% had gone bankrupt.
- Micro
- 2 to 5 years old
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
Another 0.3% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of MorphogeniQ itself: 1.3% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,976 companies, not a prediction for MorphogeniQ. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Filings with the National Bank (1)
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 25-08-2026 | 2026-00421947 |
Board & ownership
Directors
Owners and capital
Shareholders
- Meeuwissen,Luc François Isabelle all shares
- shares transferred
- MEEUWISSEN Luc François Isabelle founder
- AERTS Michel founder
Capital transactions
- 25-07-2024 Incorporation · 10,000 shares
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| Luc Meeuwissen |
|
| Michel Aerts |
|
Network & group
Companies at the same address
4 other companies- Future Roots vzw Registered office · since 22-12-2025Founded in 2025 1031.980.327
- Napagro Registered office · since 29-04-2016Founded in 2016 · total assets €204,199 (2025) 0652.985.390
- Vento Et Aqua Registered office · since 12-10-2009Founded in 2009 · total assets €371,264 (2025) 0819.553.493
- Medisch Kabinet Dr Sofie Lizin Registered office · since 14-11-2007Founded in 2007 · total assets €883,490 (2025) 0893.479.074
Connections & network
4 connected companiesTimeline
Deeds, filings and financial milestones
28-11
Gazette deed
Resignation: Michel Aerts (statutory director)Appointment: Meeuwissen, Luc François Isabelle (director) · Meeuwissen, Luc François Isabelle holds all the shares3 points ▸
- Meeuwissen, Luc François Isabelle holds all the shares
- Director resignation, Michel Aerts (statutory director)
- Director appointment, Meeuwissen, Luc François Isabelle
- The deed holds 1 more point.
25-07
Gazette deed
IncorporationFounders: MEEUWISSEN Luc François Isabelle and AERTS Michel · 10,000 shares · Appointments: MEEUWISSEN Luc François Isabelle (statutory director) and AERTS Michel (statutory director)8 points ▸
- Incorporation, 03-07-2024
- Founder, MEEUWISSEN Luc François Isabelle
- Founder, AERTS Michel
- 10,000 shares
- Registered office clause, Roeststraat 10, 2370 Arendonk
- Board rule, 2
- Director appointment, MEEUWISSEN Luc François Isabelle (statutory director)
- Director appointment, AERTS Michel (statutory director)
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
Activities
NACEBEL 2025Codes under NACEBEL 2008
3 activities
- Grond-, hulpstoffen en machines aan te kopen, desgevallend ze te bewerken en te verkopen zowel aan bedrijven als particulieren.
- Het produceren en verkopen van grondstoffen, half fabrikaten en afgewerkte producten voor professionele en particuliere afnemers.
- Het aanbieden van management, consultancy, het uitvoeren van interim management opdrachten, het verlenen van bedrijfsadvies, het deelnemen in andere bedrijven, het aanbieden van diensten en producten met betrekking tot de sport- en vrijetijdssector, de gezondheids-, welzijns- en wellnesssector, de landbouwsector, de waterzuivering, de materiaalbewerking, de textielsector en de elektronicasector.
Invoicing and payment
Financial year and general meeting
Accounts at the NBBSites & property
Buildings and parcels at the address
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 13001A0503/00K000 | Flanders | 2,579 m² | 1 · 229 m² | 9.9 m · 2 |